NEW YORK (GenomeWeb News) – A pan-European effort to develop diagnostics for a range of genetic disorders will work with CLC Bio to develop high-throughput sequencing and analysis technologies, the Danish company said today.
The EU-funded Techgene project collaborators will use the Genomics Workbench in its effort to incorporate massively parallel sequencing in routine diagnostic labs. The project will focus on a number of model disorders that have shown varying degrees of genetic complexity, such as hereditary breast cancer, ataxias, mental retardation, and sensory diseases such as blindness and deafness.
"Being part of the Techgene project provides an excellent opportunity to develop a solid solution for diagnostics using amplicon high throughput resequencing in conjunction with some of the most esteemed institutions," Patrick Dekker, a senior bioinformatics specialist at CLC Bio, said in a statement.
Dekker said that the software workbench will provide the researchers with the capacity to diagnose patients based on chromosomal and gene regions, to locate SNPs, deletion and insertion polymorphisms, and copy number variations.
Financial terms of the agreement were not released.